World Health Organization (WHO) issued a warning after identifying counterfeit versions of medications used to treat type 2 diabetes and obesity.
Three specific batches of fake semaglutide, branded as Ozempic, were discovered in Brazil, the United Kingdom, and the United States. However, the WHO’s Global Surveillance and Monitoring System (GSMS) has seen a rise in reports of fake semaglutide products worldwide since 2022.
“We urge healthcare professionals, regulatory authorities, and the public to be aware of these falsified medicines,” said Dr. Yukiko Nakatani, World HO Assistant Director-General for Access to Medicines and Health Products. “Stop using any suspicious medicines and report them to the relevant authorities.”
Semaglutides are a crucial tool for managing type 2 diabetes by regulating blood sugar and reducing heart disease risks. They are typically administered via weekly injections or daily pills, and in some countries, they are also used for weight management.
The increasing world popularity of semaglutide treatments has unfortunately led to a rise in counterfeits. These fake medicines can be hazardous as they may not contain the correct ingredients, such as insulin. This can result in uncontrolled blood sugar or other serious health complications.
While semaglutides are effective, it’s important to note that they are expensive and not universally recommended by the World HO for diabetes management. More affordable alternatives can offer similar benefits for blood sugar and heart health.
The WHO is currently also developing guidelines to assist doctors in using semaglutides for adult obesity treatment. Their goal is to ensure patients with chronic health conditions receive proper care. Read more
For safety, WHO advices the following:
- Obtain semaglutide medications from a doctor or a reputable pharmacy, not online or from unknown sources.
- Verify the packaging and follow your doctor’s instructions for use.
- If your semaglutide requires refrigeration, store it in the fridge.
- If you suspect you have a fake semaglutide product, report it directly to the World HO at rapidalert@who.int. By working together, we can protect everyone from the dangers of counterfeit medications
